Correlates and Heritability of Nonalcoholic Fatty Liver Disease in a Minority Cohort

Obesity

Volumn 17, Issue 6, 2009, Pages 1240-1246

  Wagenknecht, Lynne E ^a   Scherzinger, Ann L ^b   Stamm, Elizabeth R ^b   Hanley, Anthony J G ^c   Norris, Jill M ^b   Chen, Yii Der I ^d   Bryer Ash, Michael ^e   Haffner, Steven M ^f   Rotter, Jerome I ^d  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ABDOMINAL FAT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; ETHNOLOGY; FATTY LIVER; FEMALE; GENETIC PREDISPOSITION; GENETICS; GLUCOSE TOLERANCE TEST; HISPANIC; HUMAN; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PEDIGREE; PHENOTYPE; PREVALENCE; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; SPLEEN; STATISTICAL MODEL; UNITED STATES;

ABDOMINAL FAT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; FATTY LIVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; HISPANIC AMERICANS; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PEDIGREE; PHENOTYPE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SOUTHWESTERN UNITED STATES; SPLEEN; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 67650496665     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.4     Document Type: Article

References (36)

1. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003;285: E906-E916.
2. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006;40:S5-S10.
3. Hamaguchi M, Kojima T, Takeda N et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143: 722-728.
4. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004;27:2444-2449.
5. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
6. Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268.
7. Browning JD, Szczepaniak LS, Dobbins R et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-1395.
8. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98: 960-967.
9. Ekstedt M, Franzen LE, Mathiesen UL et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-873.
10. Adams LA, Lymp JF, St. Sauver J et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort Study. Gastroenterology 2005;129:113-121.
11. Targher G, Bertolini L, Rodella S et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007;30:2119-2121.
12. Henkin L, Bergman RN, Bowden DW et al. Genetic epidemiology of insulin resistance and visceral adiposity: the IRAS Family Study Design and Methods. Ann Epidemiol 2003;13:211-217.
13. Wagenknecht LE, Mayer E, Rewers M et al. The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design, and recruitment results. Ann Epidemiol 1995;5:464-472.
14. Davidson LE, Kuk JL, Church TS, Ross R. Protocol for measurement of liver fat by computed tomography. J Appl Physiol 2006;100:864-868.
15. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocrine Rev 1985;6:45-86.
16. Welch S, Gebhart SSP, Bergman RN, Phillips LS. Minimal model analysis of intravenous glucose tolerance test derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990;71:1508-1518.
17. Steil GM, Volund A, Kahn SE, Bergman RN. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: suitability for use in population studies. Diabetes 1993;42: 250-256.
18. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986;23:113-122.
19. Hanley AJG, Bowden D, Wagenknecht L et al. Associations of adiponectin with body fat distribution and insulin sensitivity in non-diabetic Hispanic and African Americans. J Clin Endocrinol Metab 2007;92:2665-2671.
20. Macy EM, Hayes TE, Tracy Rp. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-58.
21. Herbert V, Lau K, Gottlieb C, Bleicher S. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965;25:1375-1384.
22. Sugiuchi H, Uji Y, Okabe H, Irie T et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin. Clin Chem 1995;41:717-723.
23. Clauss A. Rapid physiological coagulation method for the determination of f ibrinogen. Acta Haematol 1957;17:237-246.
24. Macy EM, Meilahn EN, Declerck PJ, Tracy RR Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies. Arch Pathol Lab Med 1993;117:67-70.
25. Declerck PJ, Collen D. Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays. Thromb Res Suppl 1990;10:3-9.
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
27. Kodama Y, Ng CS, Wu TT et al. Comparison of CT methods for determining the fat content of the liver. Am Roentg Soc 2007;188: 1307-1312.
28. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211.
29. Weston SR, Leyden W, Murphy R et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005;41:372-379.
30. Haffner SM, D'Agostino RB Jr, Saad MF et al. Increased insulin resistance and insulin secretion in non-diabetic African Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes 1996;45:742-748.
31. Church TS, Kuk JL, Ross R et al. Association of cardio-respiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 2006;130:2023-2030.
32. Kim SG, Kim HY, Seo JA et al. Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease. Eur J Endocrinol 2005;152:225-231.
33. Targher G, Bertolini L, Zenari L. Hypoadiponectinemia is closely associated with nonalcoholic hepatic steatosis in obese subjects. Diabetes Care 2004;27:2085-2086.
34. Targher G, Bertolini L, Scala L et al. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med 2005;22:1354-1358.
35. Brouwers MC, Cantor RM, Kono N et al. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia. J Lipid Res 2006;47: 2799-2807.
36. Bathum L, Petersen HC, Rosholm JU et al. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem 2001;47:81-87.